DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

ethanol in PC12 cells. J Pharmacol Exp Ther, 1997, 282:
1487–1495.
Tabakoff B, Hoffman PL. Adenylyl cyclases and alcohol. Adv.
Second Messenger Phosphoprotein Res, 1998, 32:173–193.
Urbano-Marquez A, Estruch R, Fernandez-Sola J, et al. The
greater risk of alcoholic cardiomyopathy and myopathy in
women compared with men. JAMA, 1995, 274:149–154.
Valenzuela CF, Harris, RA. Alcohol: Neurobiology. In,
Substance Abuse: A Comprehensive Textbook. (Lowinson, JH,
Ruiz P, Millman, RB, Langrod JB, eds.) Williams & Wilkins,
Baltimore, 1997, pp. 119–142.
Voronin K, Randall P, Myrick H, et al. Aripiprazole effects on
alcohol consumption and subjective reports in a clinical laboratory
paradigm: Possible influence of self-control. Alcohol
Clin Exp Res, 2008, 32:1954–1961.
Vernet M, Cadefau JA, Balaque A, et al. Effect of chronic alcoholism
on human muscle glycogen and glucose metabolism.
Alcohol Clin Exp Res, 1995, 19:1295–1299.
Volkow ND, Wang GJ, Hitzemann R, et al. Recovery of brain
glucose metabolism in detoxified alcoholics. Am J Psychiatry,
1994, 151:178–183.
Wall TL, Ehlers CL. Genetic influences affecting alcohol use
among Asians. Alcohol Health Res World, 1995, 19:184–189.
Wartenberg AA. Management of common medical problems. In,
Principles of Addiction Medicine, 2d ed. (Graham AW and
Shultz TK, eds.) American Society of Addiction Medicine,
Chevy Chase, MD, 1998, pp. 731–740.
Wassif WS, Preedy VR, Summers B, et al. The relationship
between muscle fibre atrophy factor, plasma carnosinase activities,
and muscle RNA and protein composition in chronic
alcoholic myopathy. Alcohol Alcohol, 1993, 28:325–331.
Whitcomb DC, Block GD. Association of acetaminophen hepatotoxicity
with fasting and ethanol use. JAMA, 1994, 272:
1845–1850.
Wilde MI, Wagstaff AJ. Acamprosate: A review of its pharmacology
and clinical potential in the management of alcohol
dependence after detoxification. Drugs, 1997, 53:
1038–1053.
647
CHAPTER 23
ETHANOL AND METHANOL